Literature DB >> 22302478

Biomarkers of antimony resistance: need for expression analysis of multiple genes to distinguish resistance phenotype in clinical isolates of Leishmania donovani.

Dhiraj Kumar1, Ruchi Singh, Vasundhra Bhandari, Arpita Kulshrestha, Narendra Singh Negi, Poonam Salotra.   

Abstract

Resistance to antimony is a major cause of failure to therapy in a large proportion of visceral leishmaniasis cases. Methods to distinguish resistant and sensitive parasite are urgently needed as the standard in vitro intracellular drug susceptibility assays are cumbersome and time consuming. Differential expression profiling studies have led to the identification of several antimony resistance-associated genes; however, their efficacy as a potential biomarker for monitoring antimony resistance remains imprecise. We analysed the expression of eight genes [antimony metabolism-associated genes - multidrug resistance protein A (MRPA), γ-glutamylcysteine synthetase (γ-GCS) and aquaporin-1 (AQP1) - and genes identified by proteome/transcriptome profiling—heat shock protein 83, mitogen-activated protein kinase 1 and histones H1, H2A and H4) in antimony-resistant (n=10) and antimony-sensitive (n=4) clinical isolates of Leishmania donovani by quantitative real-time PCR, in comparison with a lab-generated resistant and a standard sensitive isolate. We observed a significant differential expression of MRPA, histone H1 (p<0.01), γ-GCS, HSP83 (p<0.005) and histone H2A and H4 (p<0.0001) in a group of sodium antimony gluconate-resistant isolates compared to sensitive isolates. Preferential AQP1 expression was observed in all the sensitive isolates (p<0.0001). Overall, expression profile in field isolates for all the genes studied showed altered expression in majority of isolates, while in some, the expression was static. All the isolates showed a mosaic of expression pattern of the genes analysed indicating constellation of genes contributes towards the drug susceptibility of parasite. As none of the genes exhibit an absolute correlation with phenotype, targeted expression analysis of a set of genes should be considered as biomarker for distinguishing the antimony-resistant and antimony-sensitive parasite.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302478     DOI: 10.1007/s00436-012-2823-z

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  31 in total

Review 1.  Treatment options for visceral leishmaniasis.

Authors:  Margriet den Boer; Robert N Davidson
Journal:  Expert Rev Anti Infect Ther       Date:  2006-04       Impact factor: 5.091

2.  In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.

Authors:  Dhiraj Kumar; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

3.  Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.

Authors:  R Lira; S Sundar; A Makharia; R Kenney; A Gam; E Saraiva; D Sacks
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

4.  A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death.

Authors:  Baptiste Vergnes; Benjamin Gourbal; Isabelle Girard; Shyam Sundar; Jolyne Drummelsmith; Marc Ouellette
Journal:  Mol Cell Proteomics       Date:  2006-10-17       Impact factor: 5.911

5.  Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites.

Authors:  Ruchi Singh; Dhiraj Kumar; Robert C Duncan; Hira L Nakhasi; Poonam Salotra
Journal:  Int J Antimicrob Agents       Date:  2010-04-27       Impact factor: 5.283

6.  Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.

Authors:  Ricardo Rojas; Liliana Valderrama; Mabel Valderrama; Maria X Varona; Marc Ouellette; Nancy G Saravia
Journal:  J Infect Dis       Date:  2006-04-07       Impact factor: 5.226

7.  Metabolomics to unveil and understand phenotypic diversity between pathogen populations.

Authors:  Ruben t'Kindt; Richard A Scheltema; Andris Jankevics; Kirstyn Brunker; Suman Rijal; Jean-Claude Dujardin; Rainer Breitling; David G Watson; Graham H Coombs; Saskia Decuypere
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

8.  Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.

Authors:  S Sundar; T K Jha; C P Thakur; M Mishra; V R Singh; R Buffels
Journal:  Am J Trop Med Hyg       Date:  2002-02       Impact factor: 2.345

9.  Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin.

Authors:  Benjamin Gourbal; Niluefer Sonuc; Hiranmoy Bhattacharjee; Danielle Legare; Shyam Sundar; Marc Ouellette; Barry P Rosen; Rita Mukhopadhyay
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

10.  Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani.

Authors:  Mahendra Maharjan; Sushma Singh; Mitali Chatterjee; Rentala Madhubala
Journal:  Am J Trop Med Hyg       Date:  2008-07       Impact factor: 2.345

View more
  17 in total

1.  J-binding protein 1 and J-binding protein 2 expression in clinical Leishmania major no response-antimonial isolates.

Authors:  Salman Ahmadian; Gilda Eslami; Ali Fatahi; Saeede Sadat Hosseini; Mahmoud Vakili; Vahid Ajamein Fahadan; Mourad Elloumi
Journal:  J Parasit Dis       Date:  2018-11-20

Review 2.  Antimony transport mechanisms in resistant leishmania parasites.

Authors:  Frédéric Frézard; Rubens Monte-Neto; Priscila G Reis
Journal:  Biophys Rev       Date:  2014-01-25

3.  Frequency of MDR1-related p-gp overexpression in Greek Leishmania isolates.

Authors:  Johannes Austrup; Pantelis Ntais; Vasiliki Christodoulou; Jean-Pierre Dedet; Francine Pratlong; Maria Antoniou
Journal:  Parasitol Res       Date:  2014-02-07       Impact factor: 2.289

4.  Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani.

Authors:  Vasundhra Bhandari; Shyam Sundar; Jean Claude Dujardin; Poonam Salotra
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

5.  Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area.

Authors:  Fakhri Jeddi; Charles Mary; Karim Aoun; Zoubir Harrat; Aïda Bouratbine; Françoise Faraut; Rezika Benikhlef; Christelle Pomares; Francine Pratlong; Pierre Marty; Renaud Piarroux
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

6.  Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani.

Authors:  Jade-Eva Potvin; Philippe Leprohon; Marine Queffeulou; Shyam Sundar; Marc Ouellette
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 9.079

7.  Intrachromosomal amplification, locus deletion and point mutation in the aquaglyceroporin AQP1 gene in antimony resistant Leishmania (Viannia) guyanensis.

Authors:  Rubens Monte-Neto; Marie-Claude N Laffitte; Philippe Leprohon; Priscila Reis; Frédéric Frézard; Marc Ouellette
Journal:  PLoS Negl Trop Dis       Date:  2015-02-13

8.  Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani.

Authors:  Aditya Verma; Vasundhra Bhandari; Deepak Kumar Deep; Shyam Sundar; Jean Claude Dujardin; Ruchi Singh; Poonam Salotra
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-10-10       Impact factor: 4.077

9.  Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress.

Authors:  Deepak Kumar Deep; Ruchi Singh; Vasundhra Bhandari; Aditya Verma; Vanila Sharma; Saima Wajid; Shyam Sundar; V Ramesh; Jean Claude Dujardin; Poonam Salotra
Journal:  PLoS Negl Trop Dis       Date:  2017-06-02

Review 10.  Determinants of Unresponsiveness to Treatment in Cutaneous Leishmaniasis: A Focus on Anthroponotic Form Due to Leishmania tropica.

Authors:  Mehdi Bamorovat; Iraj Sharifi; Razieh Tavakoli Oliaee; Abdollah Jafarzadeh; Ahmad Khosravi
Journal:  Front Microbiol       Date:  2021-06-01       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.